Insights
Access our latest insights & resources
Sector: Healthcare
Johnson & Johnson Q1 Earnings Review and Insights on Key Issues
Fundamental, Research
Johnson & Johnson announced Q1 2024 earnings on April 16, 2024, broadly aligning...
Read more
Health Care ETFs
ETF & Mutual Fund, Research
The U.S. health care industry endured challenging conditions in 2023...
Read more
Large U.S. Pharmaceuticals: Is M&A the Remedy for Looming Risks Ahead?
Fundamental, Research
Despite the high interest rate environment during 2023, M&A activity in the health care industry...
Read more
European Materials: Unlocking the Value in North America
Fundamental, Research
Holcim intends to spin off its U.S. business, which currently represents about...
Read more
Life Science Tools and Services Q4 Earnings Preview: Low Visibility for Most in the Near Term
Fundamental, Research
LSTS companies in the US will report their Q4 2023 earnings...
Read moreDrug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices
Fundamental, Research
Drug distributors MCK, COR, and CAH have been performing significantly...
Read more
European Health Care Equipment and Services: A Mixed Bag
Fundamental, Research
CFRA sees a mixture of tailwinds and headwinds for the European Health Care Equipment and Services sector...
Read moreLife Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023
Fundamental, Research, Video
During Q2, several companies operating in the Life Science Tools and Services (LSTS) industry...
Read more
MedTech: Near-term Threat of GLP-1 Agonists is Overblown
Fundamental, Research
The market is concerned weight loss drugs (GLP-1 agonists) will...
Read moreLife Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023
Fundamental, Research
Several Life Science Tools and Services (LSTS) companies had a tough Q2, negatively...
Read more